Evidence map›Paper›PMID 18007277›Full record

ReviewMolecules (Basel, Switzerland)2005

Polymeric particulates to improve oral bioavailability of peptide drugs.

Florence Delie, María José Blanco-Príeto

Abstract readEvaluation StudyReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Novel formulations for antimicrobial peptides.International journal of molecular sciences · 2014
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. pH-Responsive nanoparticles for drug delivery.Molecular pharmaceutics · 2010
    Review
  20. Novel technologies: A weapon against tuberculosis.Indian journal of pharmacology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Florence DelieSchool of Pharmacy, 30, Quai E. Ansermet, CH-1211 Geneva 4, Switzerland. Florence.Delie@pharm.unige.ch
María José Blanco-Príeto

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as peptides, proteins and nucleic acids. Due to their sensitivity to chemical and enzymatic hydrolysis as well as a poor cellular uptake, their oral bioavailability remains very low. Despite sophisticated new delivery systems, the development of a satisfactory oral formulation remains a challenge. Among the possible strategies to improve the absorption of drugs, micro- and nanoparticles represent an exciting approach to enhance the uptake and transport of orally administered molecules. Increasing attention has been paid to their potential use as carriers for peptide drugs for oral administration. This article reviews the most common manufacturing methods for polymeric particles and the physiology of particle absorption from the gastrointestinal (GI) tract. In a second part, the use of polymeric particulate systems to improve the oral absorption of insulin is discussed.

Indexed as

Administration, OralAnimalsBiological AvailabilityGastrointestinal TractHumansIntestinal AbsorptionModels, BiologicalNanoparticlesParticle SizePeptidesPharmaceutical PreparationsPolymersPeptidesPharmaceutical PreparationsPolymers

Identifiers

PMID18007277
PMCPMC6147556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.